As of close of business last night, Biohaven Ltd’s stock clocked out at $52.06, down -4.81% from its previous closing price of $54.69. On the day, 935873 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of BHVN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.98 and its Current Ratio is at 7.98. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on February 16, 2024, initiated with a Outperform rating and assigned the stock a target price of $62.
On February 06, 2024, UBS started tracking the stock assigning a Buy rating and target price of $59.
On December 22, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $50.H.C. Wainwright initiated its Buy rating on December 22, 2023, with a $50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 29 ’23 when Antonijevic Irina sold 11,000 shares for $41.79 per share. The transaction valued at 459,662 led to the insider holds 2,535 shares of the business.
CHILDS JOHN W bought 454,545 shares of BHVN for $9,999,990 on Oct 05 ’23. The Director now owns 3,998,952 shares after completing the transaction at $22.00 per share. On Oct 05 ’23, another insider, Coric Vlad, who serves as the Chief Executive Officer of the company, bought 340,908 shares for $22.00 each. As a result, the insider paid 7,499,976 and bolstered with 833,120 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 4.25B and an Enterprise Value of 3.90B.
Stock Price History:
Over the past 52 weeks, BHVN has reached a high of $62.21, while it has fallen to a 52-week low of $12.35. The 50-Day Moving Average of the stock is 50.66, while the 200-Day Moving Average is calculated to be 32.99.
Shares Statistics:
It appears that BHVN traded 1.20M shares on average per day over the past three months and 1.67M shares per day over the past ten days. A total of 81.12M shares are outstanding, with a floating share count of 69.86M. Insiders hold about 14.45% of the company’s shares, while institutions hold 88.81% stake in the company. Shares short for BHVN as of Mar 15, 2024 were 8.63M with a Short Ratio of 7.22, compared to 6.39M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.57% and a Short% of Float of 12.23%.
Earnings Estimates
As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.55 for the current quarter, with a high estimate of -$1.27 and a low estimate of -$1.97, while EPS last year was -$1.03. The consensus estimate for the next quarter is -$1.58, with high estimates of -$1.24 and low estimates of -$1.95.
Analysts are recommending an EPS of between -$3.92 and -$7.96 for the fiscal current year, implying an average EPS of -$6.21. EPS for the following year is -$5.95, with 9 analysts recommending between -$3.85 and -$8.49.
